Cargando…
Syk: a new player in the field of breast cancer
Breast tumor development and progression are thought to occur through a complex, multistep process, including oncogene activation (eg HER2/neu) and mutation or loss of tumor suppressor genes (eg p53). Determining the function of genetic alterations in breast carcinoma tumorigenesis and metastasis ha...
Autores principales: | Stewart, Zoe A, Pietenpol, Jennifer A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138668/ https://www.ncbi.nlm.nih.gov/pubmed/11250739 http://dx.doi.org/10.1186/bcr261 |
Ejemplares similares
-
Syk and Yea Shall Find
por: Wolozin, Benjamin, et al.
Publicado: (2015) -
New Players in the Field of T1D: Anti-Peripherin B Lymphocytes
por: Kendall, Peggy L.
Publicado: (2016) -
SYK Allelic Loss and the Role of Syk-Regulated Genes in Breast Cancer Survival
por: Blancato, Jan, et al.
Publicado: (2014) -
SYK expression in human breast cancer
por: Elkak, AE, et al.
Publicado: (2005) -
Microglia rely on SYK signalling to mount neuroprotective responses in models of Alzheimer's disease and multiple sclerosis
por: Ennerfelt, Hannah, et al.
Publicado: (2023)